STOCK MARKET BSE NSE

Cipla launches RT-PCR test kit 'ViraGen' in India partnership with Ubio Biotech

The company will commence supply of the COVID-19 virus detection kit from May 25, 2021.

Published: 20th May 2021 10:59 AM  |   Last Updated: 20th May 2021 10:59 AM   |  A+A-

RT-PCR tests, COVID-19 test

Image used for representational purpose only

By PTI

NEW DELHI: Drug major Cipla on Thursday announced the commercialisation of its RT-PCR test kit 'ViraGen' for COVID-19 in India, in partnership with Ubio Biotechnology Systems.

"This launch will help address the current testing services and capacity issues while reaffirming the company's ongoing expansion in the diagnostic space," Cipla said in a regulatory filing.

Cipla will launch ViraGen test kit in the country in partnership with Ubio Biotechnology Systems, the company stated.

The company will commence supply of the COVID-19 virus detection kit from May 25, 2021.

Umang Vohra, MD and Global CEO, Cipla, said, “Cipla has been working relentlessly to ensure accessibility to treatments in this fight against COVID-19.

Guided by our core purpose of 'Caring for Life', this partnership will enable us to reach out to more people across the country at a crucial time like now”.

ViraGen is Cipla's third offering in the COVID-19 testing segment.



Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp